CivicaScript, a Utah-based nonprofit company focused on bringing lower-cost generic medicines to US consumers, announced on Tuesday the appointment of Brent J Eberle, RPh, MBA as its new president, effective 30 September.
Eberle currently serves as chief pharmacy officer at Navitus Health Solutions.
Additionally, Eberle has played a significant role in shaping drug policy at both the state and national levels. He testified before the US House of Representatives Energy and Commerce Subcommittee on Health, sharing his expertise on drug pricing, and served on the Wisconsin Governor's Task Force on Reducing Prescription Drug Prices, a bipartisan group focused on addressing the high cost of prescription medications.
Eberle is to replace CivicaScript's first president, Gina Guinasso, JD, who left in June.
Ned McCoy, Civica president and chief executive officer, said: "We are thrilled to have a business and pharmacy executive of Brent's calibre on board to lead CivicaScript on its important next stage of growth. Given CivicaScript's strong member relationship with Navitus, Brent knows the business and embodies the mission – an ideal foundation to hit the ground running."
ANI Pharmaceuticals launches generic Motegrity tablets
Hikma Pharmaceuticals USA receives FDA approval for diabetes drug
Full Circles Therapeutics advances non-viral gene editing innovation
Induction Healthcare secures national video solution contract in Ireland
Safecor Health acquires Viatris' US unit-dose packaging business
LOG Pharma Primary Packaging opens new clean room
American Regent launches 30 mL Epinephrine Injection, USP in US
EpiVax and CUBRC receive USD2m contract from US FDA
Gilead expands global access to lenacapavir for HIV prevention